<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>ajhe</PublisherName>
<JournalTitle>African Journal of Health Economics</JournalTitle>
<PISSN>C</PISSN>
<EISSN>o</EISSN>
<Volume-Issue>Volume 9 Issue 2</Volume-Issue>
<PartNumber/>
<IssueTopic>Multidisciplinary</IssueTopic>
<IssueLanguage>English</IssueLanguage>
<Season>December 2020</Season>
<SpecialIssue>N</SpecialIssue>
<SupplementaryIssue>N</SupplementaryIssue>
<IssueOA>Y</IssueOA>
<PubDate>
<Year>2020</Year>
<Month>12</Month>
<Day>1</Day>
</PubDate>
<ArticleType>Review & Research</ArticleType>
<ArticleTitle>The Changing Pattern of Healthcare Financing in Sub-Saharan Africa: Implications for Health Outcomes</ArticleTitle>
<SubTitle/>
<ArticleLanguage>English</ArticleLanguage>
<ArticleOA>Y</ArticleOA>
<FirstPage>32</FirstPage>
<LastPage>50</LastPage>
<AuthorList>
<Author>
<FirstName>M. Femi Ayadi and Akanni O.</FirstName>
<LastName>Lawanson</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>N</CorrespondingAuthor>
<ORCID/>
</Author>
</AuthorList>
<DOI>doi.org/10.35202/AJHE.2020.923250 </DOI>
<Abstract>Background: The healthcare financing landscape of sub-Saharan Africa (SSA) has been characterized in recent years by a changing mix of funding mechanisms to enhance the health status of the population.
Methods: Using data from World Development Indicators, World Governance Indicators, and World Health Organization databases (1995 – 2014), this study employs the two-step difference generalized method of moments estimation to examine the implications of the changing pattern of healthcare financing on health outcomes in thirty SSA countries. The model considers life expectancy, infant, and under-5 mortalities as health outcomes and tracks their responses to variations in healthcare financing from public expenditures, private (out of pocket) expenditures, insurance, and external funding (donor) sources.
Findings: A ten percent increase in share of funding of health insurance in total health expenditure (THE) increases life expectancy by between 2.5 and 5.6 percent, and decreases under-five mortality by between 0.16 and 0.24 percent. A ten percent increase in share of government expenditure on health in THE has the potential of increasing life expectancy by about 5 percent, while the interaction of government expenditure and an institutional variable shows a positive impact. An increase in share external funding in THE results in an increase in life expectancy and a decrease in both infant and under-five mortality. Out-of-pocket expenditure as a share of THE has no potential to promote the health of SSA population across all health outcome estimations.
Conclusions: There is need for SSA countries to build strong institutions to promote efficient healthcare systems.</Abstract>
<AbstractLanguage>English</AbstractLanguage>
<Keywords>Healthcare Financing; sub-Saharan Africa; Health Outcomes; Public Healthcare Expenditure; Private Healthcare Expenditure</Keywords>
<URLs>
<Abstract>https://ajhe.org.in/ubijournal-v1copy/journals/abstract.php?article_id=13189&title=The Changing Pattern of Healthcare Financing in Sub-Saharan Africa: Implications for Health Outcomes</Abstract>
</URLs>
<References>
<ReferencesarticleTitle>References</ReferencesarticleTitle>
<ReferencesfirstPage>16</ReferencesfirstPage>
<ReferenceslastPage>19</ReferenceslastPage>
<References>1. Lawanson AO. Public Sector Health Care Financing and Health Outcomes in Sub-Saharan African Countries. Economics of Health Sector Governance and Financing in Nigeria: Vol 1 of Essays in Honour of Professor Soyibo. 1. Ibadan: Ibadan University Press; 2012. p. 121-48.
2. Nations U. The Millenium Development Goals Report 2011. New York, USA: United Nations; 2011.
3. World, Bank. World Development Indicators 2013. Washinton DC: World Bank; 2013.
4. WHO. World Malaria Report Summary 2015 [Available from: http://apps.who.int/iris/bitstream/handle/10665/205224/WHO_HTM_GMP_2016.2_eng.pdf;jsessionid=06C9E3C8EA5E57F528F32CD4F3F6AB76?sequence=1.
5. Tandon A, Cashin C. Assessing Public Expenditure on Health from a Fiscal Space Perspective Washington DC: World Bank; 2010.
6. Yaqub JO, Ojapinwa,T.V., and Yussuff, R.O. Public Health Expenditure and Health Otcomes in Nigeria: The Impact of Governance. European Scientific Journal. 2012;8(13):189-201.
7. Islam Me. Health Systems Assessment Approach: A How-To Manual2007.
8. Arhin AA. Promising Start, but bleak future? Progress of Ghana’s National Health Insurance Schemes towards Universal Health Coverage. Developing Country Studies. 2013;3(13):151-9.
9. Imurana BA, Haruna RK, Kofi A-BN. The Politics of Public Policy and Problems of Implementation in Africa: An Appraisal of Ghana’ National Health Insurance Scheme in Ga East District. International Journal of Humanities and Social Sciences. 2014;4(4).
10. Health Mo. Rwanda Community Based Health Insurance Policy Kigali2010 [Available from: https://www.moh.gov.rw/fileadmin/templates/Docs/Mutual_policy_document_final1.pdf.
11. Gerdtham U-G, Ruhm CJ. Deaths rise in good economic times: evidence from the OECD. Economics And Human Biology. 2006;4(3):298-316.
12. Novignon J, Olakojo SA, Nonvignon J. The effects of public and private health care expenditure on health status in sub-Saharan Africa: new evidence from panel data analysis. Health Economics Review. 2012;2(1):22-.
13. Farag M, Nandakumar AK, Wallack S, Hodgkin D, Gaumer G, Erbil C. Health expenditures, health outcomes and the role of good governance. International Journal Of Health Care Finance And Economics. 2013;13(1):33-52.
14. Filmer D, Pritchett L. The impact of public spending on health: does money matter? Social Science and; Medicine (1982). 1999;49(10):1309-23.
15. Gupta S, Verhoeven M, Tiongson E. Does Higher Government Spending Buy Better Results in Education and Health Care? 1999.
16. Or Z. Determinants of Health Outcomes in Industrialized Countries: A Pooled, Cross-COuntry, Time Series Analysis. OECD Economic Studies 2000;30.
17. Deluna RJTP. Public Health Expenditures, Income and Health Outcomes in the Phillipines. Munich Personal RePEc Archive Paper 60115. 2014.
18. Gwatkin DR. Reducing Health Inequalities in Developing Countries. 6th ed: Oxford University Press; 2009.
19. Pland;Uuml;Mper T, Neumayer E. Health spending, out-of-pocket contributions, and mortality rates. Public Administration. 2013;91(2):403-18.
20. Shetty A and Shetty S. The correlation of Health Spending and Infant Mortality Rate in Asian Countries. Int J Contemp Pediatr. 2014;1(2):100-5.
21. Kaushalendra K, F. Ram, and A. Singh. Public Spending on Health and Childhood Mortality in India. Munich Personal RePEc Archive Paper 48680. 2013.
22. Odhiambo SA, Anthony Wambugu, Tabitha Kiriti-Ng’ang’a. Has Quality of Governance Affected the Effectiveness of Health Expenditure on Adult Health in Sub-Saharan Africa? Europuean Scientific Journal. 2015;11(16).
23. Kulkarni L. Health Inputs, Health Outcomes and Public Health Expenditure: Evidence from the BRICS Countries. International Journal of Applied Economics. 2016;13(1):72-84.
24. Mishra P, Newhouse D. Does health aid matter? Journal Of Health Economics. 2009;28(4):855-72.
25. Moullan Y. Can Foreign Health Assistance Reduce the Medical Brain Drain? Journal of Development Studies. 2013;49(10):1436-52.
26. Makuta I, Oand;#39;Hare B. Quality of governance, public spending on health and health status in Sub Saharan Africa: a panel data regression analysis. BMC Public Health. 2015;15:932-.
27. Novignon J. On the Efficiency of Public Health Expenditure in sub-Saharan Africa: Does Corruption and Quality of Public Institutions matter? Munich Personal RePEc Archive Paper 39195. 2015.
28. Ahmad R, Hasan J. Public Health Expenditure, Governance and Health Outcomes in Malaysia. Jurnal Ekonomi Malaysia. 2016;50(1):29-40.
29. Mathauer I, Carrin G. The role of institutional design and organizational practice for health financing performance and universal coverage. Health Policy (Amsterdam, Netherlands). 2011;99(3):183-92.
30. de la Maisonneuve C, Moreno-Serra R, Murtin F, Oliveira Martins J. The Role of Policy and Institutions on Health Spending. Health Economics. 2017;26(7):834-43.
31. Gupta S, Davoodi H, Tiongson E. Corruption and the Provision of Health Care and Education Services. 2000.
32. Rajkumar AS, Swaroop V. Public Spending and Outcomes: Does Governance Matter? Journal of Development Economics. 2008;86(1):96-111.
33. Besley T, Kudamatsu M. Health and Democracy. The American Economic Review. 2006;96(2):313-8.
34. Holmberg S, Rothstein B. Dying of Corruption. Health Economics, Policy and Law. 2011;6(4):529-47.
35. Hu B, Mendoza RU. Public Health Spending, Governance and Child Health Outcomes: Revisiting the Links. Journal of Human Development and Capabilities. 2013;14(2):285-311.
36. Sommers BD, Gawande AA, Baicker K. Health Insurance Coverage and Health - What the Recent Evidence Tells Us. New England Journal of Medicine. 2017;377(6):586-93.
37. Shartzer A, Long SK, Anderson N. Access To Care And Affordability Have Improved Following Affordable Care Act Implementation; Problems Remain. Health Affairs (Project Hope). 2016;35(1):161-8.
38. Collins SR, Gunja M, Doty MM, Beutel S. Americansand;#39; Experiences with ACA Marketplace and Medicaid Coverage: Access to Care and Satisfaction: Findings from the Commonwealth Fund Affordable Care Act Tracking Survey, February–April 2016. Issue Brief (Commonwealth Fund). 2016;14:1-18.
39. Sommers BD, Blendon RJ, Orav EJ, Epstein AM. Changes in Utilization and Health Among Low-Income Adults After Medicaid Expansion or Expanded Private Insurance. JAMA Internal Medicine. 2016;176(10):1501-9.
40. Sommers BD, Gunja MZ, Finegold K, Musco T. Changes in Self-reported Insurance Coverage, Access to Care, and Health Under the Affordable Care Act. JAMA. 2015;314(4):366-74.
41. Ghosh A, Simon K, Sommers BD. The Effect of State Medicaid Expansions on Prescription Drug Use: Evidence from the Affordable Care Act. 2017.
42. Chou S-Y, Grossman M, Liu J-T. The impact of National Health Insurance on birth outcomes: A natural experiment in Taiwan. Journal of Development Economics. 2014;111:75-91.
43. Cheng L, Liu H, Zhang Y, Shen K, Zeng Y. The impact of health insurance on health outcomes and spending of the elderly: evidence from Chinaand;#39;s New Cooperative Medical Scheme. Health Economics. 2015;24(6):672-91.
44. Nixon J, Ulmann P. The Relationship between Health Care Expenditure and Health Outcomes: Evidence and Caveats for a Causal Link. European Journal of Health Economics. 2006;7(1):7-18.
45. Sen A. Mortality as an Indicator of Economic Success and Failure. Economic Journal. 1998;108(446):1-25.
46. Martin S, Rice N, Smith PC. Does Health Care Spending Improve Health Outcomes? Evidence from English Programme Budgeting Data. Journal of Health Economics. 2008;27(4):826-42.
47. Asongu SA, Nwachukwu JC. Revolution Empirics: Predicting the Arab Spring. Empirical Economics. 2016;51(2):439-82.
48. Ajide KB, Raheem ID. Institutions-FDI Nexus in ECOWAS Countries. Journal of African Business. 2016;17(3):319-41.
49. Wagstaff A. Health Spending and Aid as Escape Routes from the Vicious Circle of Poverty and Health. 2002.
50. Wagstaff A, Claeson M. The Millennium Development Goals for health: Rising to the challenges: Washington, D.C.:
World Bank; 2004. xv p.</References>
</References>
</Journal>
</Article>
</ArticleSet>